Botanix Pharmaceuticals Limited
BXPHF
$0.04
$0.0010.88%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.89M | -10.86M | -17.78M | -17.41M | -10.06M |
| Total Depreciation and Amortization | 389.30K | 388.10K | 367.00K | 359.40K | 364.30K |
| Total Amortization of Deferred Charges | -- | -- | 1.64M | 1.60M | -- |
| Total Other Non-Cash Items | 570.60K | 568.80K | 6.85M | 6.70M | -257.90K |
| Change in Net Operating Assets | -- | -- | -6.45M | -6.32M | -- |
| Cash from Operations | -9.93M | -9.90M | -15.38M | -15.06M | -9.96M |
| Capital Expenditure | -700.00 | -700.00 | -62.70K | -61.40K | -29.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -144.20K | -143.70K | 0.00 | 0.00 | -248.70K |
| Cash from Investing | -144.90K | -144.50K | -62.70K | -61.40K | -278.20K |
| Total Debt Issued | -- | -- | 14.20M | 14.20M | -- |
| Total Debt Repaid | -103.00K | -103.00K | -65.50K | -65.50K | -30.80K |
| Issuance of Common Stock | 10.50K | 10.50K | 20.00M | 20.00M | 231.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.18M | -1.18M | -1.65M | -1.65M | -- |
| Cash from Financing | -838.40K | -835.80K | 20.81M | 20.37M | 130.50K |
| Foreign Exchange rate Adjustments | -28.60K | -28.50K | -66.60K | -65.20K | 46.90K |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | -- | -- | -- |
| Net Change in Cash | -10.95M | -10.91M | 5.29M | 5.18M | -10.06M |